Globus Medical (GMED) Other Non-Current Liabilities (2011 - 2026)
Globus Medical's (GMED) quarterly Other Non-Current Liabilities came in at $19.0 million in Q2 2026, down 13.67% on a YoY basis from $22.1 million in Q2 2025, and down 7.44% quarter-over-quarter from $20.6 million in Q1 2026.
Analysis
Globus Medical (GMED) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends
Globus Medical (GMED) has reported Other Non-Current Liabilities for 16 consecutive years, with $19.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities fell 13.67% year-over-year to $19.0 million; the trailing twelve-month figure through Jun 2026 stood at $19.0 million (down 13.67% YoY), and the FY2025 full-year result was $21.3 million, down 0.87% from the prior year.
- Other Non-Current Liabilities eased to $19.0 million in Q2 2026 per GMED's latest filing, from $20.6 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $25.5 million in Q1 2025 and bottomed at $10.3 million in Q4 2022.
- Historically, Other Non-Current Liabilities has averaged $19.3 million across 5 years, with a median of $21.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities decreased 26.97% in 2022, then soared 137.76% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $10.3 million in 2022, then jumped by 137.76% to $24.6 million in 2023, then slipped by 12.46% to $21.5 million in 2024, then declined by 0.87% to $21.3 million in 2025, then decreased by 10.76% to $19.0 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $19.0 million, $20.6 million, and $21.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Globus Medical | 9.94 Bn | 9.35 Bn | 548.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.05 Mn |
| Mar 31, 2026 | 20.58 Mn |
| Dec 31, 2025 | 21.34 Mn |
| Sep 30, 2025 | 25.08 Mn |
| Jun 30, 2025 | 22.06 Mn |
| Mar 31, 2025 | 25.49 Mn |
| Dec 31, 2024 | 21.53 Mn |
| Sep 30, 2024 | 22.98 Mn |
| Jun 30, 2024 | 25.21 Mn |
| Mar 31, 2024 | 23.51 Mn |
| Dec 31, 2023 | 24.60 Mn |
| Sep 30, 2023 | 22.40 Mn |
| Jun 30, 2023 | 14.43 Mn |
| Mar 31, 2023 | 13.40 Mn |
| Dec 31, 2022 | 10.35 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 11.40 Mn |
| Mar 31, 2022 | 11.52 Mn |
| Dec 31, 2021 | 12.64 Mn |
| Sep 30, 2021 | 15.88 Mn |